Nektar Therapeutics (NKTR) Debt Ratio (2011 - 2020)

Nektar Therapeutics' Debt Ratio history runs 10 years deep, the most recent figure standing at 0.27 for Q1 2020.

• On a quarterly basis, Debt Ratio rose 136.08% year-over-year to 0.27 in Q1 2020; TTM through Mar 2020 was 0.27, a 136.08% increase from a year earlier, with the FY2019 full-year figure at 0.13, up 11.36% from the prior year.
• Debt Ratio improved to 0.27 in Q1 2020 per NKTR's latest filing, from 0.13 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.57 in Q3 2016 and bottomed at 0.11 in Q2 2018.
• The 5-year median for Debt Ratio is 0.42 (2017), against an average of 0.32.
• Across the five-year window, Debt Ratio slumped 79.28% in 2018 and surged 136.08% in 2020, its largest moves.
• Year by year, Debt Ratio stood at 0.43 in 2016, then increased by 12.59% to 0.48 in 2017, then slumped by 76.17% to 0.11 in 2018, then increased by 11.36% to 0.13 in 2019, then surged by 110.78% to 0.27 in 2020.
• Per Business Quant, the three latest NKTR Debt Ratio figures stand at 0.27 (Q1 2020), 0.13 (Q4 2019), and 0.12 (Q3 2019).